Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas Koshy Yohannan"'
Autor:
Lucia Baratto, Sonya Youngju Park, Negin Hatami, Praveen Gulaka, Shreyas Vasanawala, Thomas Koshy Yohannan, Robert Herfkens, Ronald Witteles, Andrei Iagaru
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-7 (2018)
Abstract Background Florbetaben, a 18F-labeled stilbene derivative (Neuraceq®, formerly known as BAY-949172), is a diagnostic radiopharmaceutical developed to visualize β-amyloid plaques in the brain. Here, we report a pilot study evaluating patien
Externí odkaz:
https://doaj.org/article/0ba25c32dbbc40e891e80aae6b1c8bd4
Autor:
Peter R. Carroll, Courtney Lawhn-Heath, Robert R. Flavell, Felix Y. Feng, Thomas Koshy Yohannan, Kirsten L. Greene, Spencer C. Behr, Thomas A. Hope
Publikováno v:
American Journal of Roentgenology. 213:266-274
OBJECTIVE. The purpose of this study was to determine the diagnostic accuracy of 68Ga-labeled prostate-specific membrane antigen 11 (PSMA-11) PET for disease detection in patients with prostate cancer who have biochemically recurrent disease after ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b673be88ff22c998cdb39d405d356c9
https://doi.org/10.2214/ajr.18.20699
https://doi.org/10.2214/ajr.18.20699
Autor:
Lucia Baratto, Erik Mittra, Thomas Koshy Yohannan, Sunil Reddy, Sandhya Srinivas, Akira Toriihara, Negin Hatami, Tomomi Nobashi
Publikováno v:
Clinical nuclear medicine. 44(4)
To investigate whether the evaluation of tumors, lymphoid cell-rich organs, and immune-related adverse events (IRAE) with F-FDG PET/CT can predict the efficacy and outcome of immunotherapy.Forty patients who underwent F-FDG-PET/CT scans before and af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee67af7c129c4a713a50533b747cf3a4
https://pubmed.ncbi.nlm.nih.gov/30688730
https://pubmed.ncbi.nlm.nih.gov/30688730
Autor:
Sonya Youngju Park, Shreyas S. Vasanawala, Lucia Baratto, Thomas Koshy Yohannan, Ronald M. Witteles, Robert J. Herfkens, Negin Hatami, Praveen Gulaka, Andrei Iagaru
Publikováno v:
EJNMMI Research
EJNMMI Research, Vol 8, Iss 1, Pp 1-7 (2018)
EJNMMI Research, Vol 8, Iss 1, Pp 1-7 (2018)
Background Florbetaben, a 18F-labeled stilbene derivative (Neuraceq®, formerly known as BAY-949172), is a diagnostic radiopharmaceutical developed to visualize β-amyloid plaques in the brain. Here, we report a pilot study evaluating patients with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2254d5ea4350fa41c440b049667d09ee
http://europepmc.org/articles/PMC6057864
http://europepmc.org/articles/PMC6057864